A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 134 participants.

Also called NCT05961787

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 134 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05961787
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05961787. Randomized; no masking; primary purpose treatment. Start 2022-12-30 (actual); primary completion 2025-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)
Acronym
LARGE-ONE
Intervention (Device)
SeQuent® Please drug coating balloon(DCB),Firehawk family drug eluting stent(DES)
Lead sponsor
Shanghai MicroPort Medical (Group) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05961787
Content hash
8a27ea8a7d5faf45c75d5b869b3dfae9b1484ed37c72f392c384a424ea00ace5